Mary Immaculate Hospital — Newport News, Virginia

Mary Immaculate Hospital is a clinical research site located in Newport News, Virginia, United States 23602.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Mary Immaculate Hospital has participated in 7 clinical trials.

Therapeutic areas: Hypertension, Portal, Non-Alcoholic Steatohepatitis (NASH), Non-alcoholic Steatohepatitis (NASH).

Sponsors: Galectin Therapeutics Inc., Gilead Sciences, Immuron Ltd..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Immaculate Hospital?

Mary Immaculate Hospital has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Immaculate Hospital conducted?

Mary Immaculate Hospital has 7 clinical trials on record. Their work covers Hypertension, Portal, Non-Alcoholic Steatohepatitis (NASH), Non-alcoholic Steatohepatitis (NASH).

Is Mary Immaculate Hospital accredited by Crixeo Health?

Yes — Mary Immaculate Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mary Immaculate Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.